{"log_id": 4791912589394660413, "direction": 0, "words_result_num": 87, "words_result": [{"probability": {"variance": 0.004493, "average": 0.978776, "min": 0.660412}, "location": {"width": 522, "top": 4, "height": 41, "left": 35}, "words": "现长期毒性效应,其生长、发育、性征和内分泌均未改变"}, {"probability": {"variance": 0.003418, "average": 0.974584, "min": 0.63073}, "location": {"width": 1005, "top": 41, "height": 53, "left": 74}, "words": "老年患者的生理机能比较低下,需观察患者的状态,注意用量及间隔,慎重给药。其安全性和有效性尚未建立"}, {"probability": {"variance": 2.7e-05, "average": 0.996105, "min": 0.985789}, "location": {"width": 99, "top": 41, "height": 24, "left": 55}, "words": "老年用药】"}, {"probability": {"variance": 1e-06, "average": 0.998335, "min": 0.996148}, "location": {"width": 140, "top": 86, "height": 28, "left": 53}, "words": "药物相互作用】"}, {"probability": {"variance": 0.021611, "average": 0.939319, "min": 0.431122}, "location": {"width": 549, "top": 101, "height": 43, "left": 76}, "words": "尚不完全清楚对促进白细胞释放之药物(如锂剂)应慎用"}, {"probability": {"variance": 1.2e-05, "average": 0.994879, "min": 0.990194}, "location": {"width": 92, "top": 138, "height": 28, "left": 53}, "words": "药物过量"}, {"probability": {"variance": 0.002439, "average": 0.98449, "min": 0.666607}, "location": {"width": 1190, "top": 138, "height": 53, "left": 78}, "words": "当使用本品超过安全剂量时,会出现尿隐血,尿蛋白阳性,血清碱性酸酶活性明显提高,但在五周恢复期后各项指标均可恢复正常"}, {"probability": {"variance": 0.003584, "average": 0.969426, "min": 0.701278}, "location": {"width": 1246, "top": 160, "height": 59, "left": 37}, "words": "当注射本品剂量严重超过安全剂量时,会出现食欲减退,体重偏低,活动减等现象,出现尿隐血,尿蛋白阳性;肝脏出现明显病变,这"}, {"probability": {"variance": 0.004953, "average": 0.97065, "min": 0.728595}, "location": {"width": 313, "top": 208, "height": 30, "left": 43}, "words": "些变化可以在恢复期后消除或减轻"}, {"probability": {"variance": 0.001199, "average": 0.977934, "min": 0.918088}, "location": {"width": 84, "top": 237, "height": 24, "left": 61}, "words": "临床试验"}, {"probability": {"variance": 0.005483, "average": 0.972429, "min": 0.579987}, "location": {"width": 1199, "top": 237, "height": 55, "left": 78}, "words": "给药方法:自化疗药物(不包括强地公)给药结束后48小时起,每日一次皮下注射 rhg-csf Sugg,连续注射14天,或疗程>7天"}, {"probability": {"variance": 0.007886, "average": 0.932205, "min": 0.691758}, "location": {"width": 503, "top": 276, "height": 41, "left": 37}, "words": "后连续两次ANC25.0×10L(或WBC>100×10°L停药"}, {"probability": {"variance": 0.006496, "average": 0.975875, "min": 0.404172}, "location": {"width": 1195, "top": 286, "height": 55, "left": 78}, "words": "研究对象:年龄1470岁的肿瘤患者,预计生存时间3个月以上,无血液系统疾病,心、肝、肾等主要器功能正常,属化疗初治"}, {"probability": {"variance": 0.000483, "average": 0.989739, "min": 0.909941}, "location": {"width": 363, "top": 328, "height": 37, "left": 37}, "words": "病例或既往放疗、化疗停止一月以上者"}, {"probability": {"variance": 0.001323, "average": 0.978862, "min": 0.864236}, "location": {"width": 297, "top": 359, "height": 26, "left": 80}, "words": "主要观察指标:WBC及ANC值"}, {"probability": {"variance": 1.8e-05, "average": 0.997245, "min": 0.98843}, "location": {"width": 123, "top": 385, "height": 24, "left": 82}, "words": "临床试验结果"}, {"probability": {"variance": 0.01094, "average": 0.953486, "min": 0.383162}, "location": {"width": 668, "top": 396, "height": 45, "left": 80}, "words": "试验组WBC最低值(3.67±1.93×10L)明显高于对照组WBC最低值(2"}, {"probability": {"variance": 0.008011, "average": 0.949187, "min": 0.593078}, "location": {"width": 476, "top": 390, "height": 37, "left": 811}, "words": "89×103L),试验组ANC最低值(2.13±1.42×10°L)"}, {"probability": {"variance": 0.007943, "average": 0.956184, "min": 0.652532}, "location": {"width": 324, "top": 435, "height": 26, "left": 39}, "words": "显著高于对照组WBC最低值(099"}, {"probability": {"variance": 0.013081, "average": 0.82912, "min": 0.636323}, "location": {"width": 140, "top": 429, "height": 33, "left": 437}, "words": "0/L)(P<001)"}, {"probability": {"variance": 0.013102, "average": 0.919062, "min": 0.605092}, "location": {"width": 295, "top": 460, "height": 24, "left": 86}, "words": "化疗第21天试验组WBC值(.13"}, {"probability": {"variance": 0.049594, "average": 0.829536, "min": 0.39651}, "location": {"width": 198, "top": 452, "height": 30, "left": 454}, "words": "0)明显高于对照组"}, {"probability": {"variance": 0.033085, "average": 0.853267, "min": 0.454568}, "location": {"width": 569, "top": 441, "height": 33, "left": 699}, "words": "2.41×10L).试验组ANC值(6.76±4.10×10°/L显著高于对照组"}, {"probability": {"variance": 0.030731, "average": 0.897735, "min": 0.354322}, "location": {"width": 235, "top": 487, "height": 26, "left": 39}, "words": "2.70±1.91×10°/L)(P0.01"}, {"probability": {"variance": 0.014266, "average": 0.938485, "min": 0.354523}, "location": {"width": 1199, "top": 489, "height": 53, "left": 82}, "words": "化疗第21天试验组WBC<4.0×10°/L病例数8例显著少于对照组(32例)试验组ANC<2.0×10病例数(2例)显苦少于对照组(24"}, {"probability": {"variance": 0.001791, "average": 0.977969, "min": 0.797719}, "location": {"width": 1192, "top": 538, "height": 53, "left": 84}, "words": "试验组在注射 tbgi-csf后WBC明显升高并在用药后第4、12天分别出现两个峰值,停药后WBC逐渐降低,ANC明显升高,并在"}, {"probability": {"variance": 0.006019, "average": 0.928321, "min": 0.747688}, "location": {"width": 101, "top": 540, "height": 24, "left": 47}, "words": "列)(P<0.01)"}, {"probability": {"variance": 0.006876, "average": 0.96984, "min": 0.493827}, "location": {"width": 1236, "top": 565, "height": 53, "left": 47}, "words": "用药后的第4、10-12天分别出现两个锋值,停药后ANC逐渐降低。对照组则在相对应的期间出现WBC与ANC明显降低,两组间比较"}, {"probability": {"variance": 0.006246, "average": 0.941812, "min": 0.767682}, "location": {"width": 216, "top": 610, "height": 28, "left": 51}, "words": "非常显著差异(P<0.01"}, {"probability": {"variance": 0.007614, "average": 0.96717, "min": 0.582529}, "location": {"width": 1203, "top": 612, "height": 55, "left": 84}, "words": "不良反应:主要有轻到中度发热骨肌肉疼痛,感冒样症状,注射局部红肿硬结,上述不良反应一般多为轻度,不需作特殊处理,试"}, {"probability": {"variance": 0.000117, "average": 0.991342, "min": 0.958007}, "location": {"width": 672, "top": 652, "height": 41, "left": 41}, "words": "验组无因 ithg-csh毒副作用出组病例,未见有肝肾功能心电图异常病例"}, {"probability": {"variance": 0.00733, "average": 0.946808, "min": 0.798723}, "location": {"width": 92, "top": 689, "height": 24, "left": 57}, "words": "药理毒理"}, {"probability": {"variance": 0.015976, "average": 0.938433, "min": 0.497795}, "location": {"width": 1195, "top": 689, "height": 53, "left": 88}, "words": "药理:本品为利用基因重组技术生产的人粒细胞刺激因子( rhg-csf1与天然产品相比,生物活性在体内、外基本一致,rG-CSF"}, {"probability": {"variance": 0.00498, "average": 0.969883, "min": 0.652097}, "location": {"width": 1217, "top": 716, "height": 53, "left": 41}, "words": "是调节骨髓中粒系造血的主要细胞因子之一,选择性作用于粒系造血祖细胞,促进其增殖、分化,并可增加粒系终末分化细胞的功能"}, {"probability": {"variance": 0.006683, "average": 0.971296, "min": 0.424073}, "location": {"width": 1145, "top": 765, "height": 53, "left": 88}, "words": "急性毒性:小鼠尾静脉一次注射5040gkg本品,相当于般临床注射用剂量的10倍,连续观察10天,未观察到中毒反应"}, {"probability": {"variance": 0.024914, "average": 0.841537, "min": 0.683696}, "location": {"width": 57, "top": 765, "height": 22, "left": 94}, "words": "毒理"}, {"probability": {"variance": 0.009686, "average": 0.94976, "min": 0.548502}, "location": {"width": 1203, "top": 788, "height": 57, "left": 90}, "words": "亚急性毒性:给药4周(静脉、皮下注射).13周(静脉注射)的无作用剂量为1ugg日.给予10gkg日以上时,可见鼠"}, {"probability": {"variance": 0.008244, "average": 0.96314, "min": 0.576618}, "location": {"width": 1221, "top": 815, "height": 53, "left": 45}, "words": "后肢股骨内膜的骨吸收与骨形成ALP上升、脾脏重量增加等现象。在4周13周给药(静脉注射)试验中:这些现象在停药后消失"}, {"probability": {"variance": 0.022246, "average": 0.93649, "min": 0.371208}, "location": {"width": 1240, "top": 840, "height": 53, "left": 53}, "words": "时猴给药4周、13周(静注射)的无作用剂量分别为10μgkg日1μg/kg日以上,用100gkg/日的剂量给药4周后发生急剧的白细"}, {"probability": {"variance": 0.010219, "average": 0.962746, "min": 0.428083}, "location": {"width": 1250, "top": 864, "height": 53, "left": 45}, "words": "胸数增加(为给药前的1528),被认为是发生脑出血死亡的原因,而用10gkg日的剂量给药13周未出现死亡。另外,在各个有效"}, {"probability": {"variance": 0.002933, "average": 0.981706, "min": 0.60725}, "location": {"width": 1248, "top": 891, "height": 51, "left": 45}, "words": "剂量内可见骨髓中的原红细胞减少、脾脏肿大等现象。13周给药试验在停药以后,上述现象恢复正常。幼鼠的试验结果与成年鼠的结果"}, {"probability": {"variance": 0.000523, "average": 0.988209, "min": 0.910558}, "location": {"width": 299, "top": 937, "height": 26, "left": 66}, "words": "样,药理作用及毒性均未见差异"}, {"probability": {"variance": 0.012913, "average": 0.946284, "min": 0.437588}, "location": {"width": 1199, "top": 939, "height": 55, "left": 94}, "words": "慢性毒生:180ug/g给 Beagle狗连续皮下注射 rhg-csf29天可产生较明显的毒副反应,主要表现为间性体温升高,食欲减退,部"}, {"probability": {"variance": 0.009722, "average": 0.967092, "min": 0.421803}, "location": {"width": 1234, "top": 965, "height": 51, "left": 47}, "words": "分动物心电图导T波倒置加深,注射部位皮肤增厚或出现红斑,皮下组织高度水肿,炎性细胞大片浸润,局灶性片状坏死,部分动物"}, {"probability": {"variance": 0.016312, "average": 0.936948, "min": 0.504659}, "location": {"width": 1236, "top": 992, "height": 51, "left": 47}, "words": "骨链原始细胞塔生,脾脏增大,脾细抱增长活跃,AST和TBi一过性增高,个别动物肝细胞有病理改变,但上述变化在停药30天可恢"}, {"probability": {"variance": 0.007809, "average": 0.973423, "min": 0.431595}, "location": {"width": 1242, "top": 1017, "height": 51, "left": 49}, "words": "复正常。60g/kg剂量长期给药可产生轻度的毒性反应,主要表现为部分动物发热,食欲减退,对注射局部皮肤组织的刺激性损伤,对骨"}, {"probability": {"variance": 0.024015, "average": 0.929499, "min": 0.372935}, "location": {"width": 1240, "top": 1042, "height": 53, "left": 51}, "words": "雅和裤产生比I80gk剂量较轻的可逆性病理变化。20g/kg剂量长期给药未见对 Beagle狗产生明显的毒性反应 rhg-csf20gkg长"}, {"probability": {"variance": 0.012718, "average": 0.947735, "min": 0.538711}, "location": {"width": 1238, "top": 1067, "height": 53, "left": 51}, "words": "期皮下注射对 Beagle狗是安全剂量,该剂量为本品临床常用剂量5ugkg的4倍,mhG-CSF连续皮下注射90天对大鼠的毒性随剂量的增加"}, {"probability": {"variance": 0.003949, "average": 0.974209, "min": 0.603316}, "location": {"width": 1228, "top": 1091, "height": 53, "left": 51}, "words": "有明显的毒效关系,500/kg是有明显毒性的剂量,在此剂量下,动物体重1周后增长速度低于对照组,雄性动物直到试验结束仍末恢"}, {"probability": {"variance": 0.008141, "average": 0.962741, "min": 0.60535}, "location": {"width": 1228, "top": 1118, "height": 49, "left": 51}, "words": "复到正常水平,且差异显著。AST于30天时一过性增高,超出正常范围。与造血有关的指标中,骨髓象30天的粒系比例校对照组升高"}, {"probability": {"variance": 0.0218, "average": 0.943349, "min": 0.363397}, "location": {"width": 1236, "top": 1143, "height": 49, "left": 51}, "words": "红系相对降低,粒红比差异显著。脾的脏器系数在30、60天时明显高于对照组和其他各组。网织红细胞也高于对照组,其他标未见明"}, {"probability": {"variance": 0.00906, "average": 0.969841, "min": 0.481002}, "location": {"width": 1240, "top": 1166, "height": 53, "left": 51}, "words": "显异常,100μgkg可认为是基本无性反应的剂量,为临床常用剂量的20倍.该组动物给药3周、4周时,动物有短时的体重降低,30"}, {"probability": {"variance": 0.013764, "average": 0.95179, "min": 0.434885}, "location": {"width": 1228, "top": 1192, "height": 51, "left": 59}, "words": "天时网织红细胞一过性较对照组升高,骨髓象中粒红比明显离于对照组,可能是该的对粒系的药效反应。201g/kg为安全剂量,是临床"}, {"probability": {"variance": 0.006348, "average": 0.966168, "min": 0.566518}, "location": {"width": 1242, "top": 1217, "height": 53, "left": 53}, "words": "用剂量的4倍,在90天连续给药过程中均未见本品对动物有明显的毒性影响,仅骨髓象中粒红比例对照组高,考虑为制品本身的药效"}, {"probability": {"variance": 0.00052, "average": 0.97666, "min": 0.953857}, "location": {"width": 43, "top": 1269, "height": 22, "left": 53}, "words": "作用"}, {"probability": {"variance": 0.004331, "average": 0.981057, "min": 0.550964}, "location": {"width": 1199, "top": 1267, "height": 51, "left": 97}, "words": "生殖毒性:分别在鼠妊娠前、妊娠初期和器官形成期给药(静脉注射),对亲代动物的生殖能力、胎儿、新生鼠的无作用剂量均为"}, {"probability": {"variance": 0.030424, "average": 0.905507, "min": 0.352208}, "location": {"width": 1236, "top": 1292, "height": 57, "left": 59}, "words": "00k/日以上.在国产期、哺乳期给药,对亲代动物的生殖能力、新生鼠的无作用剂量分别为100gkg日以上、4gkg日,在20gkg"}, {"probability": {"variance": 0.007829, "average": 0.964474, "min": 0.494081}, "location": {"width": 1238, "top": 1318, "height": 53, "left": 55}, "words": "日以上时可见新生鼠的发育抑制。另外,在兔器官形成期给药(静脉注射),对亲代动物的生殖能力、胎儿的无作用剂量分别为20ug/kg"}, {"probability": {"variance": 0.01242, "average": 0.944366, "min": 0.524945}, "location": {"width": 1242, "top": 1343, "height": 53, "left": 55}, "words": "日、5gkg日,在80ug/kg/日时日现母体动物的泌尿生殖器出血伴流产,在20g/kg/日以上时存活的抬儿数减少,所有的试验中均未见致"}, {"probability": {"variance": 0.00867, "average": 0.931716, "min": 0.800039}, "location": {"width": 63, "top": 1393, "height": 22, "left": 55}, "words": "畸作用"}, {"probability": {"variance": 0.006061, "average": 0.964163, "min": 0.590877}, "location": {"width": 1199, "top": 1393, "height": 51, "left": 99}, "words": "抗原性:给豚鼠、兔及同时用免疫增强剂(FCA或氢氧化铝凝胶)时出现抗原性,而在单独给药时未见抗原性,用免做大肠杆菌"}, {"probability": {"variance": 0.003663, "average": 0.971699, "min": 0.740337}, "location": {"width": 1240, "top": 1417, "height": 53, "left": 61}, "words": "种蛋白抗原性试验,并用FCA时可见抗体效价升高,而单独用本药时未见抗体效价的升高。另外,在临床试验中,未发现针对本药的"}, {"probability": {"variance": 0.000268, "average": 0.991851, "min": 0.930744}, "location": {"width": 518, "top": 1457, "height": 39, "left": 59}, "words": "抗体产生及来源于大肠杆菌的异种蛋白的抗体效价的升高"}, {"probability": {"variance": 0.009676, "average": 0.960614, "min": 0.506799}, "location": {"width": 738, "top": 1477, "height": 43, "left": 99}, "words": "其他:全身过敏反应试验、致突变试验、局部刺激性试验及致热试验均未见异常"}, {"probability": {"variance": 0.000221, "average": 0.992645, "min": 0.956401}, "location": {"width": 130, "top": 1514, "height": 26, "left": 63}, "words": "【药代动力学】"}, {"probability": {"variance": 0.004614, "average": 0.969855, "min": 0.634502}, "location": {"width": 1201, "top": 1519, "height": 51, "left": 99}, "words": "本品经静泳或皮下注射后主要分布在肾脏、骨随和血浆中,以氨基酸代谢途径被降解,并主要由尿排泄。经皮下注射时,半衰期为"}, {"probability": {"variance": 0.020352, "average": 0.92352, "min": 0.45015}, "location": {"width": 218, "top": 1566, "height": 24, "left": 90}, "words": "小时,请除率为0.5-0.7m"}, {"probability": {"variance": 0.021808, "average": 0.920285, "min": 0.59356}, "location": {"width": 204, "top": 1591, "height": 22, "left": 78}, "words": "贮藏】2-8C避光保存"}, {"probability": {"variance": 0.008158, "average": 0.960991, "min": 0.653669}, "location": {"width": 532, "top": 1605, "height": 41, "left": 76}, "words": "包装】药用溴化丁基橡胶塞、中性硼硅玻璃管制注射剂瓶"}, {"probability": {"variance": 0.017252, "average": 0.926282, "min": 0.596797}, "location": {"width": 309, "top": 1638, "height": 28, "left": 113}, "words": "包装规格:75μg支,每支0.5ml"}, {"probability": {"variance": 0.014824, "average": 0.936597, "min": 0.616499}, "location": {"width": 132, "top": 1663, "height": 26, "left": 235}, "words": "50ug支,每支"}, {"probability": {"variance": 0.010969, "average": 0.931616, "min": 0.622117}, "location": {"width": 194, "top": 1690, "height": 26, "left": 229}, "words": "20μg/支,每支10m"}, {"probability": {"variance": 0.003517, "average": 0.938782, "min": 0.796091}, "location": {"width": 175, "top": 1715, "height": 28, "left": 233}, "words": "00ug/支,每支10"}, {"probability": {"variance": 0.000377, "average": 0.991863, "min": 0.940496}, "location": {"width": 165, "top": 1739, "height": 28, "left": 80}, "words": "有效期】24个月"}, {"probability": {"variance": 0.00062, "average": 0.990039, "min": 0.870744}, "location": {"width": 542, "top": 1756, "height": 41, "left": 80}, "words": "执行标准】《中华人民共和国药典》2010年版第二增补本"}, {"probability": {"variance": 0, "average": 0.999397, "min": 0.998894}, "location": {"width": 66, "top": 1793, "height": 24, "left": 80}, "words": "批准文"}, {"probability": {"variance": 0.027016, "average": 0.893132, "min": 0.426125}, "location": {"width": 181, "top": 1816, "height": 24, "left": 210}, "words": "国药准字000000"}, {"probability": {"variance": 2e-06, "average": 0.997873, "min": 0.995913}, "location": {"width": 84, "top": 1838, "height": 28, "left": 210}, "words": "国药准字"}, {"probability": {"variance": 0.001211, "average": 0.970548, "min": 0.921439}, "location": {"width": 37, "top": 1838, "height": 22, "left": 361}, "words": "010"}, {"probability": {"variance": 0.008749, "average": 0.90613, "min": 0.809574}, "location": {"width": 82, "top": 1865, "height": 26, "left": 212}, "words": "国药准字"}, {"probability": {"variance": 1e-06, "average": 0.998488, "min": 0.997596}, "location": {"width": 82, "top": 1890, "height": 26, "left": 212}, "words": "国药准字"}, {"probability": {"variance": 0, "average": 0.999375, "min": 0.998176}, "location": {"width": 107, "top": 1917, "height": 26, "left": 74}, "words": "【生产企业"}, {"probability": {"variance": 0.000301, "average": 0.989307, "min": 0.937631}, "location": {"width": 485, "top": 1933, "height": 39, "left": 105}, "words": "企业名称:石药集团百克(山东)生物制药有限公司"}, {"probability": {"variance": 0.001471, "average": 0.978725, "min": 0.855648}, "location": {"width": 524, "top": 1956, "height": 39, "left": 111}, "words": "生产地址:烟台市牟平区沁水韩国工业园金坤大街212号"}, {"probability": {"variance": 0.001001, "average": 0.974572, "min": 0.901529}, "location": {"width": 154, "top": 1995, "height": 20, "left": 119}, "words": "政编码:264100"}, {"probability": {"variance": 0.00029, "average": 0.988902, "min": 0.94779}, "location": {"width": 140, "top": 2018, "height": 24, "left": 109}, "words": "电话号码:053"}, {"probability": {"variance": 0.001151, "average": 0.977498, "min": 0.898085}, "location": {"width": 117, "top": 2043, "height": 24, "left": 117}, "words": "专真号码:05"}], "language": -1}